{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:01:23Z","timestamp":1794013283597,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.labinv.2023.100199","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T11:22:03Z","timestamp":1686914523000},"page":"100199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of Proprotein Convertase Subtilisin\/Kexin Type 9 Inhibition on Podocytes in Mouse Nephrotic Syndrome"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9531-7814","authenticated-orcid":false,"given":"Taihei","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Iyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.labinv.2023.100199_bib3","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/jcp.25930","article-title":"NLRP3 inflammasome: its regulation and involvement in atherosclerosis","volume":"233","author":"Hoseini","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"issue":"4","key":"10.1016\/j.labinv.2023.100199_bib4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/j.ajkd.2013.10.042","article-title":"Plasma PCSK9 in nephrotic syndrome and in peritoneal dialysis: a cross-sectional study","volume":"63","author":"Jin","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.labinv.2023.100199_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.labinv.2023.100199_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.labinv.2023.100199_bib7","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/ndt\/gfz122","article-title":"Proprotein convertase subtilisin\/kexin type 9 in kidney disease","volume":"34","author":"Schmit","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.labinv.2023.100199_bib8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.kint.2020.06.045","article-title":"Secretion of the epithelial sodium channel chaperone PCSK9 from the cortical collecting duct links sodium retention with hypercholesterolemia in nephrotic syndrome","volume":"98","author":"Molina-Jijon","year":"2020","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.115.020912","article-title":"The role of proprotein convertase subtilisin\/kexin type 9 in nephrotic syndrome-associated hypercholesterolemia","volume":"134","author":"Haas","year":"2016","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.labinv.2023.100199_bib10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa2019910","article-title":"Evolocumab in pediatric heterozygous familial hypercholesterolemia","volume":"383","author":"Santos","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.labinv.2023.100199_bib11","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12882-017-0644-0","article-title":"Successful treatment of a patient with refractory nephrotic syndrome with PCSK9 inhibitors: a case report","volume":"18","author":"Awanami","year":"2017","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.labinv.2023.100199_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s13730-020-00481-x","article-title":"Effective improvement of minimal change nephrotic syndrome with uncontrollable high low-density lipoprotein cholesterol level using evolocumab accompanied by the development of acute pancreatitis","volume":"9","author":"Asai","year":"2020","journal-title":"CEN Case Rep"},{"issue":"4","key":"10.1016\/j.labinv.2023.100199_bib14","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.21037\/apm-19-587","article-title":"Treatment of hyperlipidemia with proprotein convertase subtilisin\/kexin type 9 inhibitor in a patient with nephrotic syndrome: a case report","volume":"9","author":"Choi","year":"2020","journal-title":"Ann Palliat Med"},{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ekir.2020.09.046","article-title":"Efficacy and safety of PCSK9 inhibitors in hypercholesterolemia associated with refractory nephrotic syndrome","volume":"6","author":"Jatem","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.labinv.2023.100199_bib16","doi-asserted-by":"crossref","first-page":"ytab151","DOI":"10.1093\/ehjcr\/ytab151","article-title":"Effective cholesterol lowering after myocardial infarction in patients with nephrotic syndrome may require a multi-pharmacological approach: a case report","volume":"5","author":"Sjuls","year":"2021","journal-title":"Eur Heart J Case Rep"},{"issue":"6","key":"10.1016\/j.labinv.2023.100199_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067475","article-title":"Therapeutic effects of human mesenchymal stem cells in Wistar\u2013Kyoto rats with anti-glomerular basement membrane glomerulonephritis","volume":"8","author":"Suzuki","year":"2013","journal-title":"Plos One"},{"issue":"2","key":"10.1016\/j.labinv.2023.100199_bib18","doi-asserted-by":"crossref","first-page":"F244","DOI":"10.1152\/ajprenal.00113.2011","article-title":"IL-17A stimulates granulocyte colony-stimulating factor production via ERK1\/2 but not p38 or JNK in human renal proximal tubular epithelial cells","volume":"302","author":"Hirai","year":"2012","journal-title":"Am J Physiol Ren Physiol"},{"issue":"7","key":"10.1016\/j.labinv.2023.100199_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"6","key":"10.1016\/j.labinv.2023.100199_bib20","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.labinv.2023.100199_bib21","article-title":"Total flavones of Abelmoschus manihot ameliorates podocyte pyroptosis and injury in high glucose conditions by targeting METTL3-dependent m6A modification-mediated NLRP3-inflammasome activation and PTEN\/PI3K\/Akt signaling","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.labinv.2023.100199_bib22","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1681\/ASN.2016020177","article-title":"Of inflammasomes and alarmins: IL-1\u03b2 and IL-1\u03b1 in kidney disease","volume":"27","author":"Anders","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.labinv.2023.100199_bib23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41581-019-0158-z","article-title":"The role of inflammasomes in kidney disease","volume":"15","author":"Komada","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1016\/j.labinv.2023.100199_bib24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/cvr\/cvy079","article-title":"PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages","volume":"114","author":"Ding","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.dsx.2018.08.021","article-title":"The influence of subclinical hypothyroidism on serum lipid profile, PCSK9 levels and CD36 expression on monocytes","volume":"13","author":"Fazaeli","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"10.1016\/j.labinv.2023.100199_bib26","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14721","article-title":"Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface-expression of LDLR and CD36 and NLRP3 inflammasome","volume":"9","author":"Cyr","year":"2021","journal-title":"Physiol Rep"},{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/jc.2013-2692","article-title":"Resveratrol and desferoxamine protect human OxLDL-treated granulosa cell subtypes from degeneration","volume":"99","author":"Schube","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.labinv.2023.100199_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrneph.2017.126","article-title":"CD36 in chronic kidney disease: novel insights and therapeutic opportunities","volume":"13","author":"Yang","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1016\/j.labinv.2023.100199_bib29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.labinv.2023.100199_bib30","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.12659\/MSM.909810","article-title":"CD36 promotes podocyte apoptosis by activating the pyrin domain-containing-3 (NLRP3) inflammasome in primary nephrotic syndrome","volume":"24","author":"Yang","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.labinv.2023.100199_bib31","article-title":"Corrigendum to \u201cCD36-mediated lipid accumulation and activation of NLRP3 inflammasome lead to podocyte injury in obesity-related glomerulopathy\u201d","volume":"2019","author":"Zhao","year":"2019","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.labinv.2023.100199_bib32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41419-021-03813-6","article-title":"CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys","volume":"12","author":"Hou","year":"2021","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.labinv.2023.100199_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.atherosclerosis.2013.01.023","article-title":"PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells","volume":"227","author":"Levy","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.labinv.2023.100199_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.593862","article-title":"Impact of PCSK9 on CTRP9-induced metabolic effects in adult rat cardiomyocytes","volume":"12","author":"Rohrbach","year":"2021","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","article-title":"PCSK9 (proprotein convertase subtilisin\/kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36","volume":"143","author":"Qi","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.labinv.2023.100199_bib36","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/ATVBAHA.115.306032","article-title":"PCSK9 induces CD36 degradation and affects long-chain fatty acid uptake and triglyceride metabolism in adipocytes and in mouse liver","volume":"35","author":"Demers","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.labinv.2023.100199_bib37","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.34067\/KID.0007022021","article-title":"Inhibitory antibodies against PCSK9 reduce surface CD36 and mitigate diet-induced renal lipotoxicity","volume":"3","author":"Byun","year":"2022","journal-title":"Kidney360"},{"issue":"4","key":"10.1016\/j.labinv.2023.100199_bib38","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.kint.2016.01.009","article-title":"Targeting the fatty acid transport protein CD36, a class B scavenger receptor, in the treatment of renal disease","volume":"89","author":"Yokoi","year":"2016","journal-title":"Kidney Int"},{"issue":"7293","key":"10.1016\/j.labinv.2023.100199_bib39","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.labinv.2023.100199_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127507","article-title":"CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress","volume":"10","author":"Hua","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.labinv.2023.100199_bib42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.kint.2015.12.043","article-title":"Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation","volume":"89","author":"Souza","year":"2016","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.labinv.2023.100199_bib43","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1161\/ATVBAHA.115.307312","article-title":"p38\u03b4 MAPK: a novel regulator of NLRP3 inflammasome activation with increased expression in coronary atherogenesis","volume":"36","author":"Rajam\u00e4ki","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib44","article-title":"Podocyte-derived microparticles promote proximal tubule fibrotic signaling via p38 MAPK and CD36","volume":"7","author":"Munkonda","year":"2018","journal-title":"J\u00a0Extracell Vesicles"},{"issue":"4","key":"10.1016\/j.labinv.2023.100199_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.mehy.2012.12.041","article-title":"A\u00a0novel mechanism of NALP3 inducing ischemia reperfusion injury by activating MAPK pathway in acute renal failure","volume":"80","author":"Hao","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.labinv.2023.100199_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.intimp.2018.07.027","article-title":"Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-\u03baB\/p38 signaling pathway in high-fat diet\/streptozotocin-induced diabetic mice","volume":"63","author":"Song","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.labinv.2023.100199_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104746","article-title":"Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet\/streptozotocin-induced diabetic mice","volume":"155","author":"Zhu","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.labinv.2023.100199_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2017.11.017","article-title":"Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages","volume":"15","author":"Lara-Guzm\u00e1n","year":"2018","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.labinv.2023.100199_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5551\/jat.RV17010","article-title":"Sphingosine 1-phosphate and atherosclerosis","volume":"25","author":"Kurano","year":"2018","journal-title":"J\u00a0Atheroscler Thromb"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683723001423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683723001423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:58:41Z","timestamp":1758398321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683723001423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0023683723001423"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2023.100199","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Proprotein Convertase Subtilisin\/Kexin Type 9 Inhibition on Podocytes in Mouse Nephrotic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2023.100199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100199"}}